Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL W FONG

Allopathic & Osteopathic Physicians Internal Medicine Advanced Heart Failure and Transplant Cardiology

NPI
1407863756
CMS profile
858415
Location
LOS ANGELES, CA

General Payments · PY2018–2024

$8,556.43

  • Reported across 55 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$6,304.32

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $5,937.50 1
Food and Beverage $334.55 10
Education $32.27 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
CVRx Inc. $5,968.43 2
Edwards Lifesciences Corporation $129.36 3
IMPULSE DYNAMICS (USA) INC. $71.96 2
Abbott Laboratories $61.63 2
Novo Nordisk AS $32.27 1
Acerta Pharma LLC $24.61 1
Alnylam Pharmaceuticals Inc. $16.06 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $795.11 18
PY2019 $530.45 8
PY2020 $66.50 1
PY2021 $113.28 4
PY2022 $333.19 6
PY2023 $413.58 6
PY2024 $6,304.32 12

Payment records · PY2024 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $24.29 03/21/2024 Food and Beverage Undisputed 01/23/2026 1125051356 CMS
Abbott Laboratories $37.34 10/22/2024 Food and Beverage Undisputed 01/23/2026 1125051358 CMS
Alnylam Pharmaceuticals Inc. $16.06 10/09/2024 Food and Beverage Undisputed 01/23/2026 1125841165 CMS
AstraZeneca Pharmaceuticals LP $24.61 03/26/2024 Food and Beverage Undisputed 01/23/2026 1104257077 CMS
CVRx Inc. $5,937.50 12/03/2024 Consulting Fee Undisputed 01/23/2026 1124770220 CMS
CVRx, Inc. $30.93 02/15/2024 Food and Beverage Undisputed 01/23/2026 1128561314 CMS
Edwards Lifesciences Corporation $82.67 03/18/2024 Food and Beverage Undisputed 01/23/2026 1138812661 CMS
Edwards Lifesciences Corporation $24.91 08/21/2024 Food and Beverage Undisputed 01/23/2026 1138812707 CMS
Edwards Lifesciences Corporation $21.78 12/05/2024 Food and Beverage Undisputed 01/23/2026 1138812741 CMS
Impulse Dynamics (USA) Inc. $40.67 03/12/2024 Food and Beverage Undisputed 01/23/2026 1100421692 CMS
Impulse Dynamics (USA) Inc. $31.29 08/14/2024 Food and Beverage Undisputed 01/23/2026 1100421697 CMS
Novo Nordisk Inc $32.27 05/09/2024 Education Undisputed 01/23/2026 1096605527 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.